6
Participants
Start Date
April 7, 2025
Primary Completion Date
November 7, 2025
Study Completion Date
April 7, 2026
[14C]ABSK011
The standard meal was taken the night before administration, and the patient was fasted for at least 10 h without drinking water overnight. The next morning, eat a low-fat meal, finish the meal within 30 minutes, and take the test drug with warm water 30 minutes (±5 minutes) after the beginning of the meal. The total volume of warm water and suspension liquid is about 240 mL. Except for meals and administration, no water was allowed 1 hour before and 1 hour after medication. No food is allowed for 4 hours after taking the medication. Throughout the study, participants received meals provided by the center at approximately the same time each day.
Beijing GoBroad Hospital, Beijing
Lead Sponsor
Abbisko Therapeutics Co, Ltd
INDUSTRY